 |
|
|
|
|
|
Treatment Next 25
|
|
Location |
|
Last Updated |
|
|
|
Details |
|
Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor (Toca 511) |
|
Los Angeles, CA
Detroit, MI
Edison, NJ
Columbus, OH
Seattle, WA |
|
02/01/2012 |
|
|
|
|
|
Details |
|
A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma |
|
San Francisco, CA |
|
05/04/2011 |
|
|
|
Details |
|
A Phase I Study of Peptide Vaccination With Tumor Associated Antigens Mixed With Montanide ISA-51VG in Pediatric Patients With Recurrent or Refractory Central Nervous System Tumors |
|
New York, NY |
|
03/10/2011 |
|
|
|
|
|
Details |
|
A Phase II Study of Gliadel, Concomitant Temozolomide and Radiation, followed by Dose Dense Therapy with Temozolomide Plus Bevacizumab (Avastin) for Newly Diagnosed Malignant High Grade Gliomas |
|
Houston, TX |
|
12/20/2010 |
|
|
|
Details |
|
BTTC08-01: Phase II Post-RT/TMZ Bevacizumab and Erlotinib for newly GBM without MGMT promoter methylation |
|
Houston, TX |
|
12/20/2010 |
|
|
|
|
|
Details |
|
Bevacizumab (Avastin) and Erlotinib (Tarceva) After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma |
|
Los Angeles, CA
Orlando, FL
Chicago, IL
Evanston, IL
Charleston, SC
Dallas, TX
Houston, TX
San Antonio, TX
Seattle, WA |
|
11/12/2010 |
|
|
|
Details |
|
A Phase 2 Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Tumors of the Brain
|
|
San Francisco, CA |
|
11/04/2010 |
|
|
|
|
|
Details |
|
A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas |
|
Duarte, CA |
|
10/22/2010 |
|
|
|
Details |
|
2006-0709: Phase I / II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults with Recurrent Glioblastoma Multiforme
|
|
Houston, TX |
|
03/30/2010 |
|
|
|
|
|
Details |
|
2006-0472: Phase I/II Trial of Irinotecan plus Lenalidomide in Adult Patients with Recurrent Glioblastoma Multiforme |
|
Houston, TX |
|
03/29/2010 |
|
|
|
Details |
|
2008-0059: Phase I/II study of sorafenib with radiation and temozolomide in newly diagnosed glioblastoma or gliosarcoma |
|
Houston, TX |
|
03/29/2010 |
|
|
|
|
|
Details |
|
2009-0651: Phase I/II adaptive randomized trial of vorinostat, erlotinib and carboplatin in adults with recurrent glioblastoma |
|
Houston, TX |
|
03/29/2010 |
|
|
|
Details |
|
BTTC08-01: Phase II Post-RT/TMZ Bevacizumab and Erlotinib for newly GBM without MGMT promoter methylation |
|
Houston, TX |
|
03/29/2010 |
|
|
|
|
|
Details |
|
ID01-310: Phase I Trial of Conditionally Replication-Competent Adenovirus (Delta-24-RGD4C) for recurrent malignant glioma |
|
Houston, TX |
|
03/29/2010 |
|
|
|
Details |
|
NABTC04-03: Phase I study of Vorinostat (SAHA) in combination with temozolomide in patiesnts with malignant gliomas |
|
Houston, TX |
|
03/29/2010 |
|
|
|
|
|
Details |
|
NABTC0701: Phase I Trial of Aflibercept (VEGF Trap)with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Malignant Gliomas |
|
Los Angeles, CA
San Francisco, CA
Boston, MA
Durham, NC
New York, NY
Pittsburgh, PA
Houston, TX
San Antonio, TX
Madison, WI |
|
03/29/2010 |
|
|
|
Details |
|
Anti-Tumor Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed Glioblastoma Multiforme During Recovery From Therapeutic Temozolomide-induced Lymphopenia |
|
Durham, NC |
|
01/24/2010 |
|
|
|
|
|
Details |
|
Phase I/II Study of GP96 Heat Shock Protein-Peptide Complex Vaccine in Patients With Recurrent or Progressive High-Grade Glioma |
|
San Francisco, CA |
|
01/24/2010 |
|
|
|
Details |
|
A Phase II study of Bevacizumab (Avastin) plus Temodar and Tarceva during and after Radiation Therapy in patients with newly diagnosed Glioblastoma or Gliosarcoma |
|
San Francisco, CA |
|
01/11/2010 |
|
|
|
|
|
Details |
|
ABTC 04-03: A Phase I Study of Vorinostat (Suberolyanilide Hydroxamic Acid [SAHA]) in Combination with Temozolomide in Patients with Malignant Gliomas |
|
San Francisco, CA |
|
01/11/2010 |
|
|
|
Details |
|
Phase II Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Spectroscopy for Target Definition in Patients with Recurrent Glioma |
|
San Francisco, CA |
|
01/11/2010 |
|
|
|
|
|
Details |
|
Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma |
|
Los Angeles, CA |
|
12/30/2009 |
|
|
|
Details |
|
A PHASE II STUDY OF GLIADEL, CONCOMITANT TEMOZOLOMIDE AND RADIATION, FOLLOWED BY DOSE DENSE THERAPY WITH TEMOZOLOMIDE PLUS BEVACIZUMAB FOR NEWLY DIAGNOSED MALIGNANT HIGH GRADE GLIOMA |
|
Cincinnati, OH |
|
12/02/2009 |
|
|
|
|
|
Details |
|
Phase II Clinical Trial of Patients with High-Grade Glioma Treated with Intra-arterial Carboplatin-based Chemotherapy, Randomized to Treatment with or without Delayed Intravenous Sodium Thiosulfate as a Potential Chemoprotectant against Severe Thrombocytopenia |
|
Cincinnati, OH |
|
12/02/2009 |
|
|
|
Details |
|
Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor |
|
Boston, MA |
|
09/06/2009 |
|
|
|
|
|
